Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

C19 steroids and C22 steroids are vital intermediates for the synthesis of steroid drugs. Compared with C19 steroids, C22 steroids are more suitable for synthesizing progesterone and adrenocortical hormones, albeit less developed. 9,22-dihydroxy-23,24-bisnorchol-4-ene-3-one(9-OHBA), due to its substituents at positions C-9 and C-22, is a beneficial and innovative steroid derivative for synthesizing corticosteroids. We focused on the C22 pathway in ATCC 35855, aiming to develop a productive strain that produces 9-OHBA. We used a mutant strain, MFΔ, that knocked out from ATCC 35855 named MFKD in this study as the original strain. Hsd4A and FadA5 are key enzymes in controlling the C19 metabolic pathway of steroids in ATCC 35855. After knocking out , MFKDΔ accumulated 81.47% 9-OHBA compared with 4.13% 9-OHBA in the strain MFKD. The double mutant MFKDΔΔ further improved the selectivity of 9-OHBA to 95.13%, and 9α-hydroxy-4-androstenedione (9-OHAD) decreased to 0.90% from 4.19%. In the end, we obtained 6.81 g/L 9-OHBA from 10 g/L phytosterols with a molar yield of 80.33%, which showed the best performance compared with formerly reported strains.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011972PMC
http://dx.doi.org/10.3390/ijms25073579DOI Listing

Publication Analysis

Top Keywords

atcc 35855
12
c19 steroids
8
steroids c22
8
c22 steroids
8
steroids
5
9-ohba
5
efficient production
4
production 922-dihydroxy-2324-bisnorchol-4-ene-3-one
4
922-dihydroxy-2324-bisnorchol-4-ene-3-one phytosterols
4
phytosterols modifying
4

Similar Publications

Article Synopsis
  • The study focused on improving the production of a steroid derivative, 9-OHBA, using a mutant strain (MFKD) from ATCC 35855, targeting the C22 metabolic pathway.
  • The mutant strain MFKDΔ achieved an 81.47% accumulation of 9-OHBA, and a double mutant MFKDΔΔ further improved selectivity to 95.13%, resulting in an impressive yield of 6.81 g/L from phytosterols, outperforming previous strains.
View Article and Find Full Text PDF

Phytosterol conversion into C9 non-hydroxylated derivatives through gene regulation in Mycobacterium fortuitum.

Appl Microbiol Biotechnol

December 2023

Lab of Biorefinery, Shanghai Advanced Research Institute, Chinese Academy of Sciences, No. 99 Haike Road, Pudong, Shanghai, 201210, China.

Androst-4-ene-3,17-dione (AD) and 22-hydroxy-23,24-bisnorchol-4-ene-3-one (4-HBC) are important drug intermediates that can be biosynthesized from phytosterols. However, the C9 hydroxylation of steroids via 3-ketosteroid 9α-hydroxylase (KSH) limits AD and 4-HBC accumulation. Five active KshAs, the oxidation component of KSH, were identified in Mycobacterium fortuitum ATCC 35855 for the first time.

View Article and Find Full Text PDF
Article Synopsis
  • 9α-hydroxyandrost-4-ene-3,17-dione (9-OHAD) is crucial for glucocorticoid drug synthesis, but its production is hampered by degradation and by-products during phytosterol biotransformation.
  • The study identified five 3-Ketosteroid-Δ-dehydrogenases (KstDs) in Mycobacterium fortuitum, with KstD2 and KstD3 notably causing the degradation of 9-OHAD.
  • Enhancements in production included creating a kstD-deficient strain that improved 9-OHAD yield by over 42%, achieving a final production of 12.21 g/L and a
View Article and Find Full Text PDF